Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 79
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 66
Drug Discovery 43
Cardiovascular Drugs 42
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biopharmaceuticals 36
Biotechnology 33
Genomics 27
Clinical Trials 21
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Central Nervous System Drugs 18
Pharmaceuticals 18
Allergy and Immunology 17
Infectious Diseases Drugs 16
Respiratory Drugs 15
Drugs by Therapeutic Area 14
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Drug Delivery 5
Gastroenterology 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Anti-Obesity Drugs 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

662 Results (Page 22 of 34)
- Relevance
  Sort by

Anaphylaxis Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

Gene Editing - Global Strategic Business Report

 Report
December 2025
383 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Nasal Polyps Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

Lower Respiratory Tract Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

Geriatric Care Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
March 2025
240 Pages
Global

From

€4404EUR$4,995USD£3,840GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Oral Cancer Treatment - Global Strategic Business Report

 Report
December 2025
279 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

$Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report

 Report
December 2025
287 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Metastatic Cancer Drugs Market - Global Strategic Business Report

 Report
December 2025
377 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Nasopharyngeal Cancer Treatment Market - Global Strategic Business Report

 Report
December 2025
288 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Personalized Cancer Medicines Market - Global Strategic Business Report

 Report
December 2025
267 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Epithelioma Treatment - Global Strategic Business Report

 Report
December 2025
380 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Blood Cancer Therapeutics - Global Strategic Business Report

 Report
December 2025
291 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Angiosarcoma Treatment Market - Global Strategic Business Report

 Report
December 2025
390 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

PD-1 and PD-L1 Inhibitors Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2204EUR$2,500USD£1,922GBP

Age-Related Macular Degeneration Market Size, Share and Trends Analysis Report by Product (Eylea, Lucentis), Disease (Wet AMD, Dry AMD), Distribution Channel, and Region 2024-2030

 Report
September 2024
100 Pages
Global

From

€5246EUR$5,950USD£4,575GBP

Autoimmune Drugs Market 2024-2028

 Report
July 2024
185 Pages
Global

From

€2204EUR$2,500USD£1,922GBP

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 Report
May 2024
129 Pages
Global

From

€4870EUR$5,524USD£4,247GBP

€5730EUR$6,499USD£4,997GBP

Skeletal Dysplasia Market

 Report
January 2024
200 Pages
Global

From

€3659EUR$4,150USD£3,191GBP

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€2480EUR$2,813USD£2,162GBP

€3306EUR$3,750USD£2,883GBP

662 Results (Page 22 of 34)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.